521221

Z-Leu-OH

97% (HPLC)

• Synonym(e): N-(Benzyloxycarbonyl)-L-leucin, N-(Benzyloxycarbonyl)-leucin, N-(Carbobenzoxy)-leucin, N-(Phenylmethoxy)-carbonyl-L-leucin, N-Carbobenzoxy-L-leucin, N-Carbobenzyloxy-L-leucin, N-Carboxy-L-leucin-N-benzylester, N-Cbz-L-leucin, Benzyloxycarbonyl-L-leucin, Benzyloxycarbonylleucin, Carbobenzoxyleucin, L-(Carbobenzyloxy)-leucin, L-N-(Benzyloxycarbonyl)-leucin, NSC 60039, Z-L-leucin
• Lineare Formel: (CH₃)₂CHCH₂CH(NHCOOCH₂C₆H₅)COOH
• CAS-Nummer: 2018-66-8
• Molekulargewicht: 265.30
• Beilstein: 1253861
• MDL-Nummer: MFCD00026494
• UNSPSC-Code: 12352200
• eCl@ss: 32160406
• PubChem Substanz-ID: 24874197
• NACRES: NA.22

Eigenschaften

• Assay: 97% (HPLC)
• Optische Aktivität: [α]20/D −17°, c = 2 in ethanol
• Enthält: ~10% solvents of crystalline
• Eignung der Reaktion: reaction type: solution phase peptide synthesis
• Brechungsindex: n20/D 1.512 (lit.)
• Dichte: 1 g/mL at 25 °C (lit.)
• Anwendung(en): peptide synthesis
• SMILES String: CC(C)C[C@H](NC(=O)OCc1ccccc1)C(O)=O
• InChI: 1S/C14H19NO4/c1-10(2)8-12(13(16)17)15-14(18)19-9-11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3,(H,15,18)(H,16,17)/t12-/m0/s1
• InChIKey: USPFMEKVPDBMCG-LBPRGKRZSA-N

Beschreibung

Anwendung

Reactant for:

• Peptide-based preparation of potential antitumor agents
• Preparation of cyclopropyl peptidomimetics
• Peptide synthesis